Stimulation of mu and delta opioid receptors induces hyperalgesia while stimulation of kappa receptors induces antinociception in the hot plate test in the naked mole-rat (Heterocephalus glaber)

Brain Research Bulletin

Volumn 71, Issue 1-3, 2006, Pages 60-68

  Towett, Philemon Kipkemoi ^a   Kanui, Titus Ikusya ^a   Juma, Francis D ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Antinociception; Hot plate test; Hyperalgesia; Opioid systems

Indexed keywords

ANALGESICS, OPIOID; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEAT; HYPERALGESIA; MALE; MOLE RATS; NARCOTIC ANTAGONISTS; NERVE FIBERS, UNMYELINATED; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; REACTION TIME; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SKIN; TEMPERATURE SENSE;

EID: 33751000760     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.08.001     Document Type: Article

References (61)

1. Ankier S.I. New hot plate tests to quantify antinociceptive and narcotic antagonists activities. Eur. J. Pharmacol. 27 (1974) 1-4
2. Baron A., Shuster L., Elefterhiou B.E., and Bailey D.W. Opiate receptors in mice: genetic differences. Life Sci. 17 (1975) 633-640
3. Bespalov A.Y., Zvartau E.E., and Beardsley P.M. Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance. Neurosci. Biobehav. Rev. 25 (2001) 343-353
4. Boyle S.J., Meecham K.G., Hunter J.C., and Hughes J. [3H]-CI-977: a highly selective ligand for the k-opioid receptor in both guinea-pig and rat forebrain. Mol. Neuropharmacol. 1 (1990) 23-29
5. Brain S.D., and Williams T.J. Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 335 (1988) 73-75
6. Catania K.C., and Remple M.C. Somatosensory cortex dominated by the representation of the teeth in the naked mole-rat brain. Proc. Natl. Acad. Sci. USA 99 (2002) 5692-5697
7. Chang A., Emmel D.W., Rossi G.C., and Pasternak G.W. Methadone analgesia in morphine-insensitive CXBK mice. Eur. J. Pharmacol. 351 (1998) 189-191
8. Chapman L.F. Mechanisms of the flare reaction in human skin. J. Invest. Dermatol. 69 (1977) 88-97
9. Chen L., and Huang L.Y. Protein kinase C reduces mg2+ block of NMDA-receptor channels as mechanism of modulation. Nature 356 (1992) 521-523
10. Corbett A.D., Gillan M.G.C., Kosterlitz H.W., McKnight A.T., and Paterson S.J. Tyr-d-Pen-Gly-Phe-l-Pen and Tyr-d-Pen-Gly-Phe-d-Pen are selective ligands for the delta-binding site. Br. J. Pharmacol. 80 (1983) 669-678
11. Corbett A.D., Gillan M.G.C., Kosterlitz H.W., McKnight A.T., Paterson S.J., and Robson L.E. Selectivities of opioid peptide analogues as agonists and antagonists at the delta receptor. Br. J. Pharmacol. 83 (1984) 271-279
12. Crish S.D., Rice F.L., Park T.J., and Comer C.M. Somatosensory organization and behaviour in naked mole-rat. I. Vibrissa-like body hairs comprise a sensory array that mediates orientation to tactile stimuli. Brain Behav. Evol. 62 (2003) 141-151
13. Dickenson A.H., and Sullivan A.F. Subcutaneous formalin-induced activity of dorsal horn neurons in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain 30 (1987) 349-360
14. Gibson J.R., McDermont J.R., Lauffart B., and Mantle D. Specificity of action of human brain alanylaminopeptidase on leu-enkephalin and dynorphin-related peptides. Neuropeptides 13 (1989) 259-262
15. Grudt T.J., and Williams J.T. Kappa-opioid receptors also increase potassium conductance. Proc. Natl. Acad. Sci. USA 90 (1993) 11429-11432
16. Hayes A.G., Skingle M., and Tyers M.B. Reversal by beta-funaltrexamine of the antonociceptive effect of opioid agonists in the rat. Br. J. Pharmacol. 88 (1986) 867-872
17. Henry E.C., Remple M.S., O'rian M.J., and Catania K.C. Organization of somatosensory cortical areas in the naked mole-rat (Heterocephalus glaber). J. Comp. Neurol. 495 (2006) 434-452
18. Horan P.J., De Costa P.R., Rice K., Haaseth R.C., Hruby V.J., and Porreca F. Differential antagonism by bremazocine and U-69593-induced antinociception by quadazocine: further evidence for functional evidence of opioid kappa receptor multiplicity in the mouse. J. Pharmacol. Exp. Ther. 266 (1993) 926-933
19. Hunskaar S., Berge O.-G., and Hole K. A modified hot plate test sensitive to mild analgesics. Behav. Brain Res. 21 (1986) 101-108
20. Jorenby D.E., Keesey R.E., and Baker T.M. Characterization of morphine's excitatory effects. Behav. Neurosci. 102 (1988) 975-985
21. Kanui T.I., and Hole K. Morphine induces aggression but not analgesia in the naked mole-rat (Heterocephalus glaber). Comp. Biochem. Physiol. 96C (1990) 131-132
22. Kanui T.I., Karim F., and Towett P.K. The formalin test in the mole-rat (Heterocephalus glaber): analgesic effects of morphine, nefopam and paracetamol. Brain Res. 600 (1993) 123-126
23. Karim F., Kanui T.I., and Mbugua S. Effects of codeine, naproxen and dexamethasone on formalin-induced pain in the naked mole rat. Neuroreport 4 (1993) 25-28
24. Kassin I., Brown B.T., Robinson C.A., and Bradley Jr. E.L. Acute tolerance in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology 74 (1991) 166-171
25. Larrinaga G., Gill J., Meana J.J., Ruiz F., Callado L.F., and Irazusta J. Aminopeptidase activity in the postmortem brain of human heroin addicts. Neurochem. Int. 46 (2005) 213-219
26. Laulin J.-P., Celerier E., Larcher A., Le Moal M., and Simonnet G. Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89 (1999) 631-636
27. Laulin J.-P., Maurette P., Corcuff J.-B., Rivat C., Chauvin M., and Simonnet G. The role of ketamine in preventing fentanyl-induced hyperlalgesia and subsequent acute morphine tolerance. Anesth. Analog. 94 (2002) 1263-1269
28. Ling G.S., Simantov R., Clark J.A., and Pasternak G.W. Naloxonazine actions in vivo. Eur. J. Pharmacol. 129 (1986) 33-38
29. Machelska H., Lobuz D., Przewlocki R., and Przewlocka B. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta, and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J. Pharmacol. Exp. Ther. 282 (1997) 977-984
30. Maggi C.A. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog. Neurobiol. 45 (1995) 1-98
31. Mao J., Price D.D., and Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their interactions. Pain 62 (1995) 259-274
32. Mattia A., Vanderah T., Mosberg H.I., and Porreca F. Lack of antinociceptive cross-tolerance between [d-Pen2, d-Pen5]enkephalin and [d-Ala2]deltorphin II in mice: evidence for receptor subtypes. J. Pharmacol. Exp. Ther. 258 (1991) 583-5878
33. McFadzean I. The ionic mechanisms underlying opioid actions. Neuropeptides 11 (1988) 173-180
34. Oku R., Satoh M., Fujii N., Otaka A., Yajima H., and Takagi H. Calcitonin gene-related peptide promotes nociception by potentiating the release of substance P from the spinal dorsal horn in rats. Brain Res. 403 (1987) 350-354
35. Olson G.A., Olson R.D., and Kastin A.J. Review of endogenous opiates: 1991. Peptides 13 (1992) 1247-1287
36. Park T.J., Comer C., Carol A., Lu Y., Hong S.H., and Rice F.L. Somatosensory organization and behaviour in naked mole-rats. II. Peripheral structures, innervation, and selective lack of neuropeptides associated with thermoregulation and pain. J. Comp. Neurol. 465 (2003) 104-120
37. Parsons C.G. NMDA receptors as targets for drug action in neuropathies. Eur. J. Pharmacol. 429 (2001) 71-78
38. Piercey M.F., Lhati R.A., and Schroeder L.A. U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse. Life Sci. 31 (1982) 1197-1200
39. 5]enkephalin in the mouse. J. Pharmacol. Exp. Ther. 241 (1987) 393-400
40. 4]deltorphin, but not [d-Pen2, d-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse. Eur. J. Pharmacol. 216 (1992) 453-456
41. Rosenthal W., Hescheler J., Trautwein W., and Schultz G. Control of voltage-dependent Ca2+ channels by G-protein coupled receptors. FASEB J. 2 (1988) 2784-2790
42. Safavi A., and Hersh L.B. Degradation of dynorphin-related peptides by the puromycin sensitive aminopeptidase and aminopeptidase M. J. Neurochem. 65 (1995) 389-395
43. Silverman J.D., and Kruger L. Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markers. J. Neurocytol. 19 (1990) 789-801
44. Sofuoglu M., Portoghese P.S., and Takemori A.E. Differential antagonism of delta opioid agonists by naltrindole (NTI) and its benzofuran analogue (NTB) in mice: evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257 (1991) 676-680
45. Spencer R.L., Hruby V.J., and Burks T.F. Body temperature response profiles for selective mu, delta, and kappa opioid agonists in restrained and unrestrained rats. J. Pharmacol. Exp. Ther. 246 (1988) 92-101
46. Stevens C.W. Relative analgesic potency of mu, delta and kappa opioids after spinal administration in amphibians. J. Pharmacol. Exp. Ther. 276 (1996) 440-448
47. Stevens C.W., Klopp A.J., and Facello J.A. Analgesic potency of mu and kappa opioids after systemic administration in amphibians. J. Pharmacol. Exp. Ther. 269 (1994) 1086-1093
48. Suh H.H., and Tseng L.F. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin-but not morphine-induced analgesia in mice. J. Pharmacol. Exp. Ther. 245 (1988) 587-593
49. Suh H.H., and Tseng L.F. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 342 (1990) 67-71
50. Suh H.H., Fujimoto J.M., and Tseng L.F. Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice. Eur. J. Pharmacol. 168 (1989) 61-70
51. Takemori A.E., Ho B.Y., Naeseth J.S., and Portoghese P.S. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246 (1988) 255-258
52. Tjolsen A., Berge O.-G., Eide P.K., Broth O.J., and Hole K. Apparent hyperalgesia after lesions of descending serotonergic pathways is due to increased tail skin temperature. Pain 33 (1988) 225-231
53. Towett P.K., and Kanui T.I. Effects of pethidine, acetylsalicylic acid, and indomethacin on pain and behavior in the mole-rat. Pharmacol. Biochem. Behav. 45 (1993) 153-159
54. Towett P.K., and Kanui T.I. Hyperalgesia following administration of morphine and pethidine in root rat (Tachyoryctes splendens). J. Vet. Pharmacol. Ther. 18 (1995) 68-71
55. Trujillo K.A., and Akil H. Opiate tolerance and dependence: recent findings and synthesis. New Biol. 10 (1991) 915-923
56. Tyers M.B. A classification of opiate receptors that mediate antinociception in animals. Br. J. Pharmacol. 69 (1980) 503-512
57. Vanderah T.D., Suenaga N.M.H., Ossipov Jr. M.H., Malan T.P., Lai J., and Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J. Neurosci. 21 (2001) 279-286
58. Vaught J.L., Mathiesen J.R., and Raffa R.B. Examination of the involvement of the mu and delta opioid receptors in analgesia using the mu-receptor deficient CXBK mouse. J. Pharmacol. Exp. Ther. 245 (1988) 13-16
59. VonVoigtlander P.F., Lahti R.A., and Ludens J.H. U-50,488: a selective and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224 (1983) 7-12
60. Yaksh T.L., Harty G.J., and Onfofrio B.M. High doses of spinal morphine produce a non-opiate receptor mediated hyperesthesia: clinical and theoretic implications. Anesthesiology 64 (1986) 590-597
61. Zhou S., Bonesera L., and Carlton S.M. Peripheral administration of NMDA, AMPA or KA results in pain behaviours in rats. Reuroreport 7 (1996) 895-900